Macquarie Group’s AngioDynamics ANGO Stock Holding History

Macquarie Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$4K	–	2243
2018 Q3	$4K	Sell	200 -15,300	-99%	-$340K	﹤0.01%	2082
2018 Q2	$345K	Sell	15,500 -1,800	-10%	-$36.8K	﹤0.01%	1481
2018 Q1	$298K	Sell	17,300 -37,469	-68%	-$625K	﹤0.01%	1568
2017 Q4	$911K	Sell	54,769 -5,795	-10%	-$98.9K	﹤0.01%	1266
2017 Q3	$1.03M	Buy	60,564 +1,047	+2%	+$17.6K	﹤0.01%	1201
2017 Q2	$965K	Buy	+59,517	New	+$941K	﹤0.01%	1174

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Macquarie Group's ANGO Position: Q4 2018 in Review

Macquarie Group sold out of AngioDynamics (ANGO) in Q4 2018, closing a stake of 200 shares — an estimated $4K sold.

Macquarie Group first reported a position in ANGO in Q2 2017 and held it in 6 quarters. The position peaked at $1.03M in Q3 2017. 174 funds tracked by Wall St. Rank hold ANGO as of Q4 2018.

Macquarie Group reported no remaining AngioDynamics position as of Q4 2018 after selling out during the quarter.
Macquarie Group sold 200 AngioDynamics shares in Q4 2018, an estimated $4K.
Macquarie Group first reported a position in AngioDynamics in Q2 2017 and held it in 6 quarters.
Macquarie Group's AngioDynamics position peaked at $1.03M in Q3 2017.
174 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2018.

Based on Macquarie Group's 13F filing for Q4 2018, filed 15 Feb 2019.